APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical (biopharma) Blister Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biopharmaceutical (biopharma) Blister Packaging Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchBiopharmaceutical (biopharma) Blister Packaging Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical (biopharma) Blister Packaging Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical (biopharma) Blister Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical (biopharma) Blister Packaging Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical (biopharma) Blister Packaging Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Biopharmaceutical (biopharma) Blister Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biopharmaceutical (biopharma) Blister Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical (biopharma) Blister Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical (biopharma) Blister Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biopharmaceutical (biopharma) Blister Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biopharmaceutical (biopharma) Blister Packaging market include Bemis, MeadWestvaco Corp, Klöckner Pentaplast, Constantia Flexibles, Tekni-plex, Honeywell, Amcor, CPH Group and Bilcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biopharmaceutical (biopharma) Blister Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical (biopharma) Blister Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical (biopharma) Blister Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biopharmaceutical (biopharma) Blister Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Biopharmaceutical (biopharma) Blister Packaging Segment by Company

Bemis

MeadWestvaco Corp

Klöckner Pentaplast

Constantia Flexibles

Tekni-plex

Honeywell

Amcor

CPH Group

Bilcare

Shanghai Haishun

Biopharmaceutical (biopharma) Blister Packaging Segment by Type

PVC

Lidding Foils

Cold Form

PVDC

Biopharmaceutical (biopharma) Blister Packaging Segment by Application

Capsule Drug

Tablets Drug

Others Drug

Biopharmaceutical (biopharma) Blister Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biopharmaceutical (biopharma) Blister Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biopharmaceutical (biopharma) Blister Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biopharmaceutical (biopharma) Blister Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Biopharmaceutical (biopharma) Blister Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical (biopharma) Blister Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical (biopharma) Blister Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical (biopharma) Blister Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biopharmaceutical (biopharma) Blister Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical (biopharma) Blister Packaging industry.

Chapter 3: Detailed analysis of Biopharmaceutical (biopharma) Blister Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biopharmaceutical (biopharma) Blister Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biopharmaceutical (biopharma) Blister Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biopharmaceutical (biopharma) Blister Packaging Industry Trends Table 2. Biopharmaceutical (biopharma) Blister Packaging Industry Drivers Table 3. Biopharmaceutical (biopharma) Blister Packaging Industry Opportunities and Challenges Table 4. Biopharmaceutical (biopharma) Blister Packaging Industry Restraints Table 5. Global Biopharmaceutical (biopharma) Blister Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biopharmaceutical (biopharma) Blister Packaging Revenue Share by Company (2021-2026) Table 7. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Biopharmaceutical (biopharma) Blister Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Biopharmaceutical (biopharma) Blister Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biopharmaceutical (biopharma) Blister Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Biopharmaceutical (biopharma) Blister Packaging Company, Product Type & Application Table 13. Global Biopharmaceutical (biopharma) Blister Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biopharmaceutical (biopharma) Blister Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PVC Table 18. Significant Companies of Lidding Foils Table 19. Significant Companies of Cold Form Table 20. Significant Companies of PVDC Table 21. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type (2021-2026) & (k units) Table 23. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type (2027-2032) & (k units) Table 24. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Type (2021-2026) Table 25. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Type (2027-2032) Table 26. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type (2021-2026) Table 30. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Capsule Drug Table 32. Significant Companies of Tablets Drug Table 33. Significant Companies of Others Drug Table 34. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application (2021-2026) & (k units) Table 36. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application (2027-2032) & (k units) Table 37. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Application (2021-2026) Table 38. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Application (2027-2032) Table 39. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application (2021-2026) Table 43. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application (2027-2032) Table 44. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region (2021-2026) & (k units) Table 46. Global Biopharmaceutical (biopharma) Blister Packaging Sales Market Share by Region (2021-2026) Table 47. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region (2027-2032) & (k units) Table 48. Global Biopharmaceutical (biopharma) Blister Packaging Sales Market Share by Region (2027-2032) Table 49. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Region (2021-2026) Table 52. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Region (2027-2032) Table 54. Global Biopharmaceutical (biopharma) Blister Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Biopharmaceutical (biopharma) Blister Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country (2021-2026) & (k units) Table 59. Global Biopharmaceutical (biopharma) Blister Packaging Sales Market Share by Country (2021-2026) Table 60. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country (2027-2032) & (k units) Table 61. Global Biopharmaceutical (biopharma) Blister Packaging Sales Market Share by Country (2027-2032) Table 62. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Market Share by Country (2021-2026) Table 64. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Market Share by Country (2027-2032) Table 66. Bemis Company Information Table 67. Bemis Business Overview Table 68. Bemis Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Bemis Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 70. Bemis Recent Development Table 71. MeadWestvaco Corp Company Information Table 72. MeadWestvaco Corp Business Overview Table 73. MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 75. MeadWestvaco Corp Recent Development Table 76. Klöckner Pentaplast Company Information Table 77. Klöckner Pentaplast Business Overview Table 78. Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 80. Klöckner Pentaplast Recent Development Table 81. Constantia Flexibles Company Information Table 82. Constantia Flexibles Business Overview Table 83. Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 85. Constantia Flexibles Recent Development Table 86. Tekni-plex Company Information Table 87. Tekni-plex Business Overview Table 88. Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 90. Tekni-plex Recent Development Table 91. Honeywell Company Information Table 92. Honeywell Business Overview Table 93. Honeywell Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Honeywell Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 95. Honeywell Recent Development Table 96. Amcor Company Information Table 97. Amcor Business Overview Table 98. Amcor Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Amcor Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 100. Amcor Recent Development Table 101. CPH Group Company Information Table 102. CPH Group Business Overview Table 103. CPH Group Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CPH Group Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 105. CPH Group Recent Development Table 106. Bilcare Company Information Table 107. Bilcare Business Overview Table 108. Bilcare Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Bilcare Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 110. Bilcare Recent Development Table 111. Shanghai Haishun Company Information Table 112. Shanghai Haishun Business Overview Table 113. Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Product Portfolio Table 115. Shanghai Haishun Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Biopharmaceutical (biopharma) Blister Packaging Distributors List Table 119. Biopharmaceutical (biopharma) Blister Packaging Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Biopharmaceutical (biopharma) Blister Packaging Product Image Figure 2. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical (biopharma) Blister Packaging Sales (2021-2032) & (k units) Figure 5. Global Biopharmaceutical (biopharma) Blister Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Biopharmaceutical (biopharma) Blister Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PVC Image Figure 10. Lidding Foils Image Figure 11. Cold Form Image Figure 12. PVDC Image Figure 13. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Type (2021-2032) Figure 16. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type (2021-2032) Figure 19. Capsule Drug Image Figure 20. Tablets Drug Image Figure 21. Others Drug Image Figure 22. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Application (2021-2032) Figure 25. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application (2021-2032) Figure 28. Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Biopharmaceutical (biopharma) Blister Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 33. North America Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 39. South America Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Biopharmaceutical (biopharma) Blister Packaging Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Biopharmaceutical (biopharma) Blister Packaging Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • PVC
  • Lidding Foils
  • Cold Form
  • PVDC
Applications
  • Capsule Drug
  • Tablets Drug
  • Others Drug
Companies covered
  • Bemis
  • MeadWestvaco Corp
  • Klöckner Pentaplast
  • Constantia Flexibles
  • Tekni-plex
  • Honeywell
  • Amcor
  • CPH Group
  • Bilcare
  • Shanghai Haishun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biopharmaceutical (biopharma) Blister Packaging Market Dynamics
  1. 2.1 Biopharmaceutical (biopharma) Blister Packaging Industry Trends
  2. 2.2 Biopharmaceutical (biopharma) Blister Packaging Industry Drivers
  3. 2.3 Biopharmaceutical (biopharma) Blister Packaging Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical (biopharma) Blister Packaging Industry Restraints
3 Biopharmaceutical (biopharma) Blister Packaging Market by Company
  1. 3.1 Global Biopharmaceutical (biopharma) Blister Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Biopharmaceutical (biopharma) Blister Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Biopharmaceutical (biopharma) Blister Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Biopharmaceutical (biopharma) Blister Packaging Company Ranking (2024-2026)
  6. 3.6 Global Biopharmaceutical (biopharma) Blister Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Biopharmaceutical (biopharma) Blister Packaging Company Product Type and Application
  8. 3.8 Global Biopharmaceutical (biopharma) Blister Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biopharmaceutical (biopharma) Blister Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biopharmaceutical (biopharma) Blister Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biopharmaceutical (biopharma) Blister Packaging Market by Type
  1. 4.1 Biopharmaceutical (biopharma) Blister Packaging Type Introduction
  2. 4.1.1 PVC
  3. 4.1.2 Lidding Foils
  4. 4.1.3 Cold Form
  5. 4.1.4 PVDC
  6. 4.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type
  7. 4.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type
  11. 4.3.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Type (2021-2032)
  13. 4.3.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type (2021-2032)
5 Biopharmaceutical (biopharma) Blister Packaging Market by Application
  1. 5.1 Biopharmaceutical (biopharma) Blister Packaging Application Introduction
  2. 5.1.1 Capsule Drug
  3. 5.1.2 Tablets Drug
  4. 5.1.3 Others Drug
  5. 5.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application
  6. 5.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application
  10. 5.3.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Application (2021-2032)
  12. 5.3.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application (2021-2032)
6 Biopharmaceutical (biopharma) Blister Packaging Regional Sales and Value Analysis
  1. 6.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Region (2027-2032)
  5. 6.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Biopharmaceutical (biopharma) Blister Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Country, 2025 VS 2032
7 Biopharmaceutical (biopharma) Blister Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales by Country (2027-2032)
  6. 7.4 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biopharmaceutical (biopharma) Blister Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biopharmaceutical (biopharma) Blister Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bemis
  2. 8.1.1 Bemis Company Information
  3. 8.1.2 Bemis Business Overview
  4. 8.1.3 Bemis Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bemis Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  6. 8.1.5 Bemis Recent Developments
  7. 8.2 MeadWestvaco Corp
  8. 8.2.1 MeadWestvaco Corp Company Information
  9. 8.2.2 MeadWestvaco Corp Business Overview
  10. 8.2.3 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MeadWestvaco Corp Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  12. 8.2.5 MeadWestvaco Corp Recent Developments
  13. 8.3 Klöckner Pentaplast
  14. 8.3.1 Klöckner Pentaplast Company Information
  15. 8.3.2 Klöckner Pentaplast Business Overview
  16. 8.3.3 Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Klöckner Pentaplast Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  18. 8.3.5 Klöckner Pentaplast Recent Developments
  19. 8.4 Constantia Flexibles
  20. 8.4.1 Constantia Flexibles Company Information
  21. 8.4.2 Constantia Flexibles Business Overview
  22. 8.4.3 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Constantia Flexibles Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  24. 8.4.5 Constantia Flexibles Recent Developments
  25. 8.5 Tekni-plex
  26. 8.5.1 Tekni-plex Company Information
  27. 8.5.2 Tekni-plex Business Overview
  28. 8.5.3 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tekni-plex Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  30. 8.5.5 Tekni-plex Recent Developments
  31. 8.6 Honeywell
  32. 8.6.1 Honeywell Company Information
  33. 8.6.2 Honeywell Business Overview
  34. 8.6.3 Honeywell Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Honeywell Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  36. 8.6.5 Honeywell Recent Developments
  37. 8.7 Amcor
  38. 8.7.1 Amcor Company Information
  39. 8.7.2 Amcor Business Overview
  40. 8.7.3 Amcor Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Amcor Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  42. 8.7.5 Amcor Recent Developments
  43. 8.8 CPH Group
  44. 8.8.1 CPH Group Company Information
  45. 8.8.2 CPH Group Business Overview
  46. 8.8.3 CPH Group Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CPH Group Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  48. 8.8.5 CPH Group Recent Developments
  49. 8.9 Bilcare
  50. 8.9.1 Bilcare Company Information
  51. 8.9.2 Bilcare Business Overview
  52. 8.9.3 Bilcare Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bilcare Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  54. 8.9.5 Bilcare Recent Developments
  55. 8.10 Shanghai Haishun
  56. 8.10.1 Shanghai Haishun Company Information
  57. 8.10.2 Shanghai Haishun Business Overview
  58. 8.10.3 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Haishun Biopharmaceutical (biopharma) Blister Packaging Product Portfolio
  60. 8.10.5 Shanghai Haishun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biopharmaceutical (biopharma) Blister Packaging Value Chain Analysis
  2. 9.1.1 Biopharmaceutical (biopharma) Blister Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biopharmaceutical (biopharma) Blister Packaging Sales Mode & Process
  6. 9.2 Biopharmaceutical (biopharma) Blister Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biopharmaceutical (biopharma) Blister Packaging Distributors
  9. 9.2.3 Biopharmaceutical (biopharma) Blister Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst